Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$2.98M Buy
69,689
+20,235
+41% +$807K 0.05% 614
2017
Q3
$1.81M Sell
49,454
-260,256
-84% -$10.5M 0.03% 701
2017
Q2
$14.1M Buy
309,710
+35,923
+13% +$1.59M 0.3% 38
2017
Q1
$11.7M Buy
273,787
+208,441
+319% +$8.5M 0.26% 67
2016
Q4
$2.62M Sell
65,346
-22,623
-26% -$873K 0.08% 433
2016
Q3
$3.42M Sell
87,969
-55,422
-39% -$2.09M 0.13% 246
2016
Q2
$4.96M Buy
143,391
+122,290
+580% +$4.23M 0.27% 83
2016
Q1
$728K Sell
21,101
-90,592
-81% -$3.16M 0.05% 471
2015
Q4
$4.32M Buy
111,693
+73,593
+193% +$2.86M 0.33% 100
2015
Q3
$1.49M Sell
38,100
-65,843
-63% -$2.61M 0.24% 158
2015
Q2
$3.96M Buy
103,943
+69,685
+203% +$2.44M 0.16% 292
2015
Q1
$1.13M Sell
34,258
-35,120
-51% -$1.08M 0.05% 557
2014
Q4
$1.85M Buy
69,378
+52,230
+305% +$1.35M 0.1% 469
2014
Q3
$417K Buy
+17,148
New +$433K 0.03% 527

Other funds holding HOLX

AHL Partners's HOLX Position: Q4 2017 in Review

AHL Partners increased its Hologic (HOLX) stake by 41% in Q4 2017, buying an estimated $807K and bringing the position to 69,689 shares worth $2.98M. The position accounts for 0.05% of the portfolio, ranked #614.

AHL Partners first reported a position in HOLX in Q3 2014 and has held it in 14 quarters since. The position peaked at $14.1M in Q2 2017. 472 funds tracked by Wall St. Rank hold HOLX as of Q4 2017.

  • AHL Partners held 69,689 shares of Hologic worth $2.98M as of Q4 2017.
  • AHL Partners bought 20,235 Hologic shares in Q4 2017, an estimated $807K.
  • Hologic made up 0.05% of AHL Partners's portfolio in Q4 2017, its #614 holding.
  • AHL Partners first reported a position in Hologic in Q3 2014 and has held it in 14 quarters since.
  • AHL Partners's Hologic position peaked at $14.1M in Q2 2017.
  • 472 funds tracked by Wall St. Rank held Hologic as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.